Washington Capital Management Inc. Increases Holdings in Humana Inc. $HUM

Washington Capital Management Inc. lifted its position in shares of Humana Inc. (NYSE:HUM) by 21.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,540 shares of the insurance provider’s stock after acquiring an additional 440 shares during the quarter. Washington Capital Management Inc.’s holdings in Humana were worth $621,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the 4th quarter worth approximately $202,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Humana by 71.8% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 323 shares of the insurance provider’s stock worth $85,000 after acquiring an additional 135 shares in the last quarter. Versant Capital Management Inc raised its position in shares of Humana by 17.1% during the 1st quarter. Versant Capital Management Inc now owns 453 shares of the insurance provider’s stock worth $120,000 after purchasing an additional 66 shares during the last quarter. Fifth Third Wealth Advisors LLC raised its position in shares of Humana by 8.6% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 1,237 shares of the insurance provider’s stock worth $327,000 after purchasing an additional 98 shares during the last quarter. Finally, Rhumbline Advisers raised its position in shares of Humana by 3.3% during the 1st quarter. Rhumbline Advisers now owns 246,037 shares of the insurance provider’s stock worth $65,101,000 after purchasing an additional 7,909 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Wall Street Zen downgraded Humana from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Morgan Stanley cut their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an “overweight” rating for the company in a research report on Thursday, August 14th. Sanford C. Bernstein lifted their price objective on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, Royal Bank Of Canada lifted their price objective on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research report on Thursday, August 21st. Seven equities research analysts have rated the stock with a Buy rating and seventeen have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $289.50.

Humana Stock Up 0.1%

HUM stock opened at $254.72 on Monday. The stock has a market capitalization of $30.64 billion, a P/E ratio of 19.55, a PEG ratio of 1.50 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a one year low of $206.87 and a one year high of $324.38. The company has a 50 day moving average price of $271.91 and a two-hundred day moving average price of $257.41.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. During the same period in the prior year, the firm earned $6.96 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s payout ratio is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.